RxSight Inc. (RXST)
RxSight Max Pain By Strike
RXST trades at $8.41, 12.1% above the near-term max pain of $7.5 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($5-$15), reflecting growing call interest at higher strikes. Key magnetic zone at 8 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
RxSight Max Pain By Expiry
Max pain for RXST shows an upward trend from 5 to 15, suggesting bullish positioning in longer-dated options. The 100% spread signals divergent expectations across timeframes. Levels distributed around 8.41. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 7.5 | -0.91 (-10.82%) |
| Sep 19, 2025 | 15 | 6.59 (78.36%) |
| Oct 17, 2025 | 15 | 6.59 (78.36%) |
| Dec 19, 2025 | 10 | 1.59 (18.91%) |
| Jan 16, 2026 | 7.5 | -0.91 (-10.82%) |
| Mar 20, 2026 | 5 | -3.41 (-40.55%) |